Source:http://linkedlifedata.com/resource/pubmed/id/21166498
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2010-12-20
|
| pubmed:abstractText |
We reviewed the medical records of 42 patients with cutaneous melanoma metastatic to the liver who underwent hepatic artery chemoembolization (HACE) at our institution. HACE resulted in radiologic response (38.9%) or disease stabilization (47.2%) in most patients. The median overall survival (OS) and time to progression (TTP) of liver disease were 7.7 and 6 months, respectively. Patient's age, lactate dehydrogenase (LDH) levels, type of treatment, number of extrahepatic metastatic sites, and response to therapy were found to be significant predictors of OS after HACE. Prolonged survival was seen in patients who responded to HACE (p = .034).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1532-4192
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
49-55
|
| pubmed:meshHeading |
pubmed-meshheading:21166498-Chemoembolization, Therapeutic,
pubmed-meshheading:21166498-Disease-Free Survival,
pubmed-meshheading:21166498-Female,
pubmed-meshheading:21166498-Hepatic Artery,
pubmed-meshheading:21166498-Humans,
pubmed-meshheading:21166498-Kaplan-Meier Estimate,
pubmed-meshheading:21166498-Liver Neoplasms,
pubmed-meshheading:21166498-Male,
pubmed-meshheading:21166498-Melanoma,
pubmed-meshheading:21166498-Middle Aged,
pubmed-meshheading:21166498-Proportional Hazards Models,
pubmed-meshheading:21166498-Retrospective Studies,
pubmed-meshheading:21166498-Risk Assessment,
pubmed-meshheading:21166498-Risk Factors,
pubmed-meshheading:21166498-Skin Neoplasms,
pubmed-meshheading:21166498-Texas,
pubmed-meshheading:21166498-Time Factors,
pubmed-meshheading:21166498-Treatment Outcome
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
|
| pubmed:affiliation |
Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
|
| pubmed:publicationType |
Journal Article
|